Aspirin "Allergy"-Induced Thrombocytopenia: A Case Report.
Wei FuShanshan XuXiang DongQing XieYa-Dong GaoPublished in: Journal of asthma and allergy (2021)
Aspirin is clinically widely used to inhibit platelet aggregation after coronary intervention. Herein we describe a case of aspirin-induced thrombocytopenia that may be related to allergy to aspirin. A 47-year-old man developed a delayed hypersensitivity reaction to aspirin, with pruritus, purpura and thrombocytopenia, increased peripheral blood eosinophils and enlarged inguinal lymph node. All the symptoms disappeared in 2 years after stopping aspirin. Aspirin-induced thrombocytopenia related to allergy is rarely reported. Aspirin hypersensitivity should be taken into consideration in case of unexplained thrombocytopenia in patients taking aspirin. Aspirin "allergy"-induced thrombocytopenia may involve both aspirin related IgG and IgE antibodies.
Keyphrases
- low dose
- cardiovascular events
- antiplatelet therapy
- drug induced
- lymph node
- anti inflammatory drugs
- high glucose
- randomized controlled trial
- coronary artery disease
- diabetic rats
- peripheral blood
- prostate cancer
- type diabetes
- atopic dermatitis
- squamous cell carcinoma
- end stage renal disease
- percutaneous coronary intervention
- radiation therapy
- newly diagnosed
- chronic kidney disease
- aortic valve
- oxidative stress
- transcatheter aortic valve replacement
- early stage
- atrial fibrillation
- aortic stenosis
- sleep quality